Position in ANTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$705,686
-$640,774 QoQ
Shares Held
145,803
-63.0% QoQ
Ownership
0.386%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 66 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ANTX ranks #231 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ANTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $705,686 | 145,803 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,346,460 | 393,702 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $439,255 | 385,312 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $489,343 | 385,310 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $408,641 | 385,511 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $524,256 | 385,483 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $531,955 | 385,475 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,344 | 16,210 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $33,616 | 15,636 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $48,658 | 14,972 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $448,607 | 21,894 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $49,767 | 3,095 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $103,836 | 12,216 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $255,790 | 25,916 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $235,523 | 24,714 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $228,824 | 13,166 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,702 | 1,639 | Shares | Defined | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||